Herantis Pharma Oyj (HEL: HRTIS)

Herantis Pharma Oyj Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	2023	2022	2021	2020	2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-0.61	0.28	-9.32	-12.77	-9.15	-8
Depreciation & Amortization	-	-	-	-	-	0.12
Other Amortization	-	-	0.16	2.72	0.93	0.93
Other Operating Activities	-4.54	-5.13	0.24	-	-0	-
Change in Accounts Receivable	0.07	-0.02	-0.1	0.04	0.05	-0.16
Change in Other Net Operating Assets	-0.87	0.23	0.08	0.07	-0.38	1.16
Operating Cash Flow	-5.95	-4.64	-8.94	-9.93	-8.56	-5.96
Sale of Property, Plant & Equipment	-	-	-	-	0	-
Investment in Securities	-0.47	-	-	-	-	-
Other Investing Activities	0	0.61	-0.21	-	-	-
Investing Cash Flow	-0.47	0.61	-0.21	-	0	-
Long-Term Debt Issued	-	-	-	-	-	0.83
Short-Term Debt Repaid	-	-0.01	-0.15	-0.01	-0.01	-0.01
Total Debt Repaid	-0.02	-0.01	-0.15	-0.01	-0.01	-0.01
Net Debt Issued (Repaid)	-0.02	-0.01	-0.15	-0.01	-0.01	0.83
Issuance of Common Stock	4.51	4.51	8.71	4.04	14.89	9.94
Financing Cash Flow	4.49	4.5	8.56	4.03	14.88	10.77
Miscellaneous Cash Flow Adjustments	0	-	-	-	-	-
Net Cash Flow	-1.94	0.47	-0.59	-5.9	6.33	4.81
Free Cash Flow	-5.95	-4.64	-8.94	-9.93	-8.56	-5.96
Free Cash Flow Per Share	-0.32	-0.27	-0.61	-0.97	-1.16	-1.02
Cash Interest Paid	0	0.02	1.09	0.31	1.08	0.85
Levered Free Cash Flow	-0.93	0.26	-4.76	-5.13	-4.5	-2.47
Unlevered Free Cash Flow	-0.93	0.27	-4.72	-5.09	-4.45	-2.43
Change in Net Working Capital	0.8	-0.17	-0.12	0.02	0.34	-1

Source: S&P Capital IQ. Standard template. Financial Sources.